cognitive disorders in young patients with diabetes mellitus type 1

Clicks: 288
ID: 182125
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #23 of 79 articles by views in Macromolecular rapid communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The article presents the data on the assessment of cognitive function in young patients with diabetes type 1 and identification of possible risk factors. The presence of hypoglycemia, diabetic retinopathy has an impact on the state of cognitive functions. Patients receiving insulin therapy based on analogues of human insulin have significantly better performance in cognitive function. Patients receiving a daily dose of insulin more than 60 IU have significantly worse performance in cognitive function according to neuropsychological tests, compared with the group that received daily insulin dose of less than 40 IU. It may also be due to the large number of patients, who have hypoglycemic events.
Reference Key
zherdova2016mnarodnijcognitive Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;N.M. Zherdova;B.M. Mankovskyi
Journal Macromolecular rapid communications
Year 2016
DOI
10.22141/2224-0721.3.75.2016.76631
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.